NewLink Genetics | Unleashing Human Potential™

- newlinkgenetics.com

NewLink Genetics is a late-stage biopharmaceutical company focusing on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer. NewLink Genetics' IDO pathway inhibitors are designed to harness multiple components of the immune system to combat ca

4,940,424 $ 240.00


NewLink Genetics | Unleashing Human Potential™

- linkp.com

NewLink Genetics is a late-stage biopharmaceutical company focusing on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer. NewLink Genetics' IDO pathway inhibitors are designed to harness multiple components of the immune system to combat ca

8,232,155 $ 240.00